Followers | 75 |
Posts | 4838 |
Boards Moderated | 2 |
Alias Born | 08/21/2015 |

Thursday, September 24, 2020 1:38:51 PM
This is my own editorial post on why this company will be one of the biggest players in this space. I was taught at a young age by a chemist that all substances on this planet have what is known as a "Therapeutic Window of Use" - meaning simply that anything dialed in correctly will show signs of positive use.
Sodium Chloride. Regular table salt can kill you easily. But a minute amount makes food taste good and is good for water retention. Hence why sports drinks contain a small amount.
Getting into more complex spaces like ADHD and other ailments like narcolepsy (which is the complete opposite of ADHD) you start to look at how some chemicals are abused to get high. For example... look at Adderall and Ritalin. Both of these drugs can speed up or slow down a person and change the chemistry in the brain. Usually having the opposite effect of what is intended if not prescribed or used correctly or as intended. This is an extremely basic case for those examples and I am not a chemist nor is this post supposed to be one.
However, when you look at the science behind LSD it becomes extremely similar in case... too much... you see things that are not there... just enough and you see things a little differently. It is tight tolerances and tweaking at it finest.
Then look at the laws and politics behind drugs... Take Ritalin for example - Ritalin (Methylphenidate) was first made in 1944 and was approved for medical use in the United States in 1955. It was originally sold by Swiss company CIBA, now Novartis Corporation. It is estimated that in 2013, 2.4 billion doses of methylphenidate were taken worldwide. In 2017, it was the 47th-most commonly prescribed medication in the United States, with more than 16 million prescriptions. It is available as a generic medication.
What becomes interesting is the time lines... prior to Ritalin... LSD was studied, synthesized, but then outlawed. Ritalin is now a generic (aka. the patent expired)
Now, even more intriguing to me is that the man behind LSD, Albert Hoffman, whom became an employee of the pharmaceutical/chemical department of Sandoz Laboratories (now a subsidiary of Novartis), located in Basel. Novartis was the company (then CIBA) who actually developed the drug... Now that psychedelics are becoming mainstream... there is a lot of IP starting to surround this. One day soon... MindMed will be the company behind a safer and more rational class of drugs to treat the illnesses which we were poisoning people at one time and still are.
Things are going to get really interesting here folks... strap in. This is not your typical OTC company at all. Something big is at play here... You thought the Cannabis Boom was big. You haven't seen anything yet. And screw the "Mush Rush"... this is even bigger than the idea of that.
Recent MNMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2025 09:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2025 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2025 09:00:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2025 08:09:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2025 08:06:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2025 08:03:55 PM
- MindMed Announces New Employee Inducement Grants • Business Wire • 03/24/2025 08:01:00 PM
- MindMed Appoints Matt Wiley as Chief Commercial Officer • Business Wire • 03/17/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2025 12:40:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 12:30:12 PM
- MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 • Business Wire • 02/20/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2025 10:28:45 PM
- MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference • Business Wire • 02/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 12:45:08 PM
- MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder • Business Wire • 01/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:31:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:31:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:30:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:39:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:30:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:28:56 PM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM
Opus Holdings, Inc. (OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints Visionary CEO to Lead Bold Transformation • CATV • Apr 10, 2025 9:34 AM
AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge • NGTF • Apr 10, 2025 9:00 AM
UAV Corp Powers Forward: T-Wing Nears Completion, Global Momentum Accelerates with Saudi Arabia in Sight • UMAV • Apr 10, 2025 8:30 AM
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV • FITY • Apr 9, 2025 9:00 AM
Nightfood Holdings (OTCQB: NGTF) Signs $41M LOI to Acquire Victorville Hotel as Model Property for Robotics-Enabled Hospitality • NGTF • Apr 8, 2025 11:21 AM